T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
1276
DELISTED
Juniper Networks
JNPR
| $12.6M | ﹤0.01% |
442,697
-39,185
| -8% | -$1.24M |
|
|
LUXE
1277
LuxExperience B.V.
LUXE
$1.04B
| $12.6M | ﹤0.01% |
1,272,204
+5,500
| +0.4% | +$62.2K |
|
1278
Globe Life
GL
$14B
| $12.5M | ﹤0.01% |
127,762
-9,383
| -7% | -$920K |
|
1279
Rigetti Computing
RGTI
$6.21B
| $12.4M | ﹤0.01% |
3,372,837
-525,163
| -13% | -$3.34M |
|
1280
Liberty Broadband Class C
LBRDK
$5.29B
| $12.3M | ﹤0.01% |
106,098
-637,686
| -86% | -$77.7M |
|
1281
Robert Half
RHI
$4.48B
| $12.2M | ﹤0.01% |
162,460
-12,645
| -7% | -$1.2M |
|
1282
Pinnacle West Capital
PNW
$12.2B
| $12.1M | ﹤0.01% |
166,035
-6,019
| -3% | -$450K |
|
1283
iShares Russell 1000 Growth ETF
IWF
$129B
| $12.1M | ﹤0.01% |
220,640
+43,696
| +25% | +$2.62M |
|
|
HLVX
1284
DELISTED
HilleVax
HLVX
| $12M | ﹤0.01% |
+1,101,237
| New | +$13.1M |
|
|
CNTA
1285
DELISTED
Centessa Pharmaceuticals
CNTA
| $12M | ﹤0.01% |
2,461,130
-67,453
| -3% | -$432K |
|
1286
Hain Celestial
HAIN
$53.9M
| $11.9M | ﹤0.01% |
503,266
-73,410
| -13% | -$2.09M |
|
1287
Blackbaud
BLKB
$2.1B
| $11.8M | ﹤0.01% |
203,055
-74,792
| -27% | -$4.35M |
|
|
UMH
1288
UMH Properties
UMH
$1.42B
| $11.8M | ﹤0.01% |
666,679
+30
| +0% | +$624 |
|
1289
Roku
ROKU
$22.9B
| $11.7M | ﹤0.01% |
142,872
-76,891
| -35% | -$7.45M |
|
1290
Immunocore
IMCR
$1.74B
| $11.7M | ﹤0.01% |
313,899
-29,380
| -9% | -$954K |
|
1291
F5
FFIV
$23.6B
| $11.6M | ﹤0.01% |
75,583
-7,060
| -9% | -$1.23M |
|
1292
Organon & Co
OGN
$3.6B
| $11.5M | ﹤0.01% |
341,283
-173,955
| -34% | -$6.09M |
|
1293
iShares Core MSCI EAFE ETF
IEFA
$196B
| $11.3M | ﹤0.01% |
191,435
+14,033
| +8% | +$900K |
|
1294
First Bancorp
FBNC
$2.74B
| $11.3M | ﹤0.01% |
322,608
-80,168
| -20% | -$2.99M |
|
1295
Red Robin
RRGB
$183M
| $11.2M | ﹤0.01% |
1,398,738
-957,730
| -41% | -$10.3M |
|
1296
Whirlpool
WHR
$2.79B
| $11.2M | ﹤0.01% |
72,408
-13,241
| -15% | -$2.3M |
|
1297
BorgWarner
BWA
$13.8B
| $11.2M | ﹤0.01% |
381,186
-30,700
| -7% | -$1.01M |
|
1298
Thryv Holdings
THRY
$96.9M
| $11.2M | ﹤0.01% |
498,267
+16,551
| +3% | +$425K |
|
1299
Zions Bancorporation
ZION
$10.5B
| $11.1M | ﹤0.01% |
218,814
-25,546
| -10% | -$1.45M |
|
1300
Genpact
G
$5.78B
| $10.9M | ﹤0.01% |
256,849
+11,811
| +5% | +$501K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.